STERIS (STE)
(Delayed Data from NYSE)
$203.90 USD
+2.36 (1.17%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $203.96 +0.06 (0.03%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
STE 203.90 +2.36(1.17%)
Will STE be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for STE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for STE
Should You Buy STERIS (STE) Stock Ahead of Q4 Earnings?
Zacks Industry Outlook Highlights Edwards Lifesciences, DexCom and STERIS
STE: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
Here's Why Steris (STE) is Poised for a Turnaround After Losing -9.06% in 4 Weeks
Here's Why Investors Should Retain STERIS (STE) Stock for Now
Other News for STE
With rate cuts pushed out, Goldman looks at quality stocks
STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024
Top 10 most oversold S&P 500 stocks
Interesting STE Put And Call Options For December 20th
Steris PLC stock underperforms Tuesday when compared to competitors